"Diagnostic and Treatment Problems of Primary Sclerosing Cholangitis" by Rezky Aulia Nurleili, Intan Airlina F et al.

Journal of Indonesian Tourism and Policy Studies

Article Title

Diagnostic and Treatment Problems of Primary Sclerosing Cholangitis

Authors

Rezky Aulia Nurleili, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia /RS dr. Cipto Mangunkusumo, Jakarta
Intan Airlina F, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia /RS dr. Cipto Mangunkusumo, Jakarta
Anna Mira Lubis, Divisi Hematologi Onkologi Medik, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia /RS dr. Cipto Mangunkusumo, JakartaFollow

Abstract

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with high incidence reported in America (1/100.000 population), but there is still no data available in Indonesia. The best management of this disease is still not found. Thus, in this article author will discuss about the case of PSC in 49-years male patients hospitalized in Cipto Mangunkusumo hospital Jakarta and its treatment.

References

1. Maggs JR, Chapman RW. An update on primary sclerosing cholangitis. Curr Opin Gastroenterol. 2008;24(3):377-83. 2. Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51(2):660-78. 3. Hirschfield GM, Karlsen TH, Lindor KD, et al. Primary sclerosing cholangitis. Lancet. 2013;382(9904):1587-99. 4. Mendes FD, Lindor KD. Primary sclerosing cholangitis. Clin Liver Dis. 2004;8(1):195-211. 5. Toy E, Balasubramanian S, Selmi C. The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population. BMC Gastroenterol. 2011;18(11):83-9. 6. Eaton JE, Talwalkar JA, Lazaridis KN, et al. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013;145(3):521-36. 7. Karlsen TH, Schrumpf E, Boberg KM. Update on primary sclerosing cholangitis. J Hepatol. 2013;59(3):571-82. 8. Guicciardi ME, Gores GJ. Cholestatic hepatocellular injury: what do we know and how should we proceed. J Hepatol. 2005;42(3):297- 300. 9. Portmann B, Zen Y. Inflammatory disease of the bile ducts cholangiopaties: liver biopsy challenge and clinicopathological correlation. Histopathology. 2012;60(2):236-48. 10. Benito de Valle M, Rahman M, Lindkvist B, et al. Factors that reduce health-related quality of life in patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2012;10(7):769-75. 11. Aljiffry M, Renfrew PD, Walsh MJ, et al. Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis. HPB (Oxford). 2011;13(2):79-90. 12. Chapman MH, Webster GJ, Bannoo S, et al. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience. Eur J Gastroenterol Hepatol. 2012;24(9):1051-8. 13. Jess T, Simonsen J, Jorgensen KT, et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143(2):375-81. 14. Soetikno RM, Lin OS, Heidenreich PA, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Edosc. 2002;56(1):48-54. 15. Harnois DM, Gores GJ, Ludwig J, et al. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol. 1997;27(3):512-6. 16. Hay JE, Lindor KD, Wiesner RH, et al. The metabolic bone disease of primary sclerosing cholangitis. Hepatology. 1991;14(2):257-6. 17. Lindkvist B, Benito de Valle M, Gullberg B, et al. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology. 2010;52(2): 571-7. 18. MacCarty RL, LaRusso NF, Wiesner RH, et al. Primary sclerosing cholangitis: findings on chlangiography and pancreatography. Radiology.1983;149(1):39-44. 19. Bjornsson E, Olsson R, Bergquist A, et al. The natural history of small-duct primary sclerosing cholangitis. Gastroenterology. 2008;134(4):975-980. 20. Hov JR, Boberg KM, Karlsen TH. Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol. 2008;14(24):3781- 91. 21. Burak KW, Angulo P, Lindor KD. Is there a role for liver biopsy in primary sclerosing cholangitis? Am J Gastroenterol. 2003;98(5):1155-8. 22. Lee YM, Kaplan MM. Management of primary sclerosing cholangitis. Am J Gastroenterol.2002;97(3):528-34. 23. European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237-67. 24. Shimizu M, Iwasaki H, Mase S. Successful treatment of primary sclerosing cholangitis with a steroid and a probiotic. Case Rep Gastroenterol. 2012;6(2):249-53.

Recommended Citation

Nurleili, Rezky Aulia; F, Intan Airlina; and Lubis, Anna Mira (2016) "Diagnostic and Treatment Problems of Primary Sclerosing Cholangitis," Journal of Indonesian Tourism and Policy Studies: Vol. 3: Iss. 1, Article 8.
Available at: https://scholarhub.ui.ac.id/jitps/vol3/iss1/8

Download

COinS